title: A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
authors.affiliation: Hematology/Oncology Division, University of Pennsylvania Health System, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA, edward.stadtmauer@uphs.upenn.edu.
authors.forename: Edward A
authors.initials: EA
authors.lastname: Stadtmauer
authors.forename: Sagar
authors.initials: S
authors.lastname: Lonial
authors.forename: David H
authors.initials: DH
authors.lastname: Vesole
authors.forename: Rafat
authors.initials: R
authors.lastname: Abonour
authors.forename: Melissa
authors.initials: M
authors.lastname: Alsina
authors.forename: Ashraf
authors.initials: A
authors.lastname: Badros
authors.forename: Raymond
authors.initials: R
authors.lastname: Comenzo
authors.forename: Brian
authors.initials: B
authors.lastname: Durie
authors.forename: Sergio
authors.initials: S
authors.lastname: Giralt
authors.forename: Mohamad
authors.initials: M
authors.lastname: Hussein
authors.forename: Andrzej
authors.initials: A
authors.lastname: Jakubowiak
authors.forename: Jayesh
authors.initials: J
authors.lastname: Mehta
authors.forename: Ruben
authors.initials: R
authors.lastname: Niesvizky
authors.forename: Robert
authors.initials: R
authors.lastname: Orlowski
authors.forename: David
authors.initials: D
authors.lastname: Siegel
authors.forename: Seema
authors.initials: S
authors.lastname: Singhal
authors.forename: Robert
authors.initials: R
authors.lastname: Vescio
authors.forename: Michael
authors.initials: M
authors.lastname: Wang
authors.forename: Maurizio
authors.initials: M
authors.lastname: Zangari
authors.forename: Nikhil C
authors.initials: NC
authors.lastname: Munshi
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide